Dube K, Eskaf S, Barr L, Palm D, et al. Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause (IMAP) in the United States: Results from the AIDS Clinical Trials Group (ACTG) A5345 Biomarker Study. AIDS Res Hum Retroviruses 2022 Mar 24. doi: 10.1089/AID.2021.0170.
PMID: 35323030